AI-based Tool Offers Highly Accurate Pancreatic Cancer Diagnostics
A new deep learning model classifies pancreatic ductal adenocarcinoma into molecular subtypes using cost-effective histopathology images.
Read More
Search Results for: pancreatic adenocarcinoma
Pancreatic Cancer Early-Detection Test Gets Positive Clinical Validation
Immunovia’s CLARITI study validated its next-generation test for early-stage pancreatic cancer, achieving 78% sensitivity and 94% specificity.
Read More
FDA Approves Roche CDx for Gastric and Gastroesophageal Junction Cancer Treatment
Roche’s VENTANA CLDN18 RxDx Assay identifies CLDN18 protein expression in gastric and gastroesophageal junction cancer patients.
Read More
Immunovia Completes Discovery Phase for Next-Gen Pancreatic Cancer Test
Immunovia, a company focused on pancreatic cancer detection, successfully completed of the discovery phase of its next-generation test.
Read More
PDACatch an FDA Breakthrough Device for Pancreatic Cancer Detection
Singlera Genomics’ PDACatch assay is a novel DNA methylation-based liquid biopsy assay for the detection of pancreatic adenocarcinoma in individuals at high risk for the disease.
Read More